Covalon to Showcase Clinical Innovation and Infection Prevention Leadership at Infusion Nurses Society 2026 Annual Meeting

Covalon Technologies Ltd. (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its upcoming presence at the Infusion Nurses Society (INS) 2026 Annual Meeting taking place in Louisville, KY from April 11 – 14, 2026. The event will bring together leading clinicians, researchers, healthcare professionals and industry leaders all dedicated to advancing vascular access and infusion therapy practice. Attendees will have the opportunity to learn more about Covalon’s innovative and unique vascular access and infection prevention solutions and learn why leading hospitals in the United States and beyond are increasingly adopting Covalon products in clinical practice.

A key area of focus for Covalon at this event will be highlighting the Company’s commitment to addressing and advancing progress on one of the most underrecognized risks in vascular access care - contamination of intravenous (IV) connections and access points. Through a combination of clinical education, real-world evidence, and innovative product solutions, Covalon will demonstrate how targeted protection strategies can help reduce the risk of patient complications, including bloodstream infections, and improve patient safety.

The conference's educational program features a podium presentation by Dr. Nancy Moureau, a globally recognized vascular access expert. Her session, titled “A Closer Look at a “Gross” Gap in Protection: What is Missing with CABSI?” addresses the critical yet frequently underrecognized challenge around gross contamination of IV connections and access points and how gaps in protection can lead to Catheter-Associated Blood Stream Infections (CABSIs). The presentation will explore how environmental exposure and routine care events contribute to infection risk, offering practical, evidence-based strategies to protect IV connections and access points and improve patient outcomes.

Covalon’s VALGuard Vascular Access Line Guard is proving to be a strong and rapidly growing solution for many hospitals and other points of care as they focus on protecting IV line connections and access points from contamination and will be featured in Covalon’s booth at the meeting.

Covalon will also showcase the rapidly increasing clinical adoption of its CovaClear IV Cover dressings. This innovative solution provides coverage to shield primary IV dressings from bodily fluids and other environmental contaminants prevalent in clinical settings. By supporting safe and efficient vascular access care and maintenance practices, Covalon aims to reduces the time, resources, and the risk associated with unplanned primary dressing changes.